Recombinant activated factor VII (rFVIIa) dosing and efficacy in the treatment of cranial hemorrhage in hemophilia patients with inhibitors: An analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004-2008) Meeting Abstract
| Authors: | Nakar, C. T.; Cooper, D. L.; DiMichele, D. |
| Abstract Title: | Recombinant activated factor VII (rFVIIa) dosing and efficacy in the treatment of cranial hemorrhage in hemophilia patients with inhibitors: An analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004-2008) |
| Meeting Title: | 50th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 112 |
| Issue: | 11 |
| Meeting Dates: | 2008 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2008-11-16 |
| Start Page: | 794 |
| End Page: | 795 |
| Language: | English |
| ACCESSION: | WOS:000262104702611 |
| PROVIDER: | wos |
| PUBMED: | 22276298 |
| DOI: | 10.1182/blood.V112.11.2278.2278 |
| Notes: | --- - Meeting Abstract: 2278 - Poster Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos" |
